Carson Thiel: Putting Patient Satisfaction First

With roots in Germany, Carsten Thiel has studied at some of the most prestigious institutions including the Max Planck Institute. There, he focused him studies on a particular protein involved in the progression of normal, healthy cells into cancer-ridden ones. He entered the pharmaceutical field when he joined the firm Hoffman La-Roche. Working as the Communication and Production manager, Thiel built a positive reputation and was offered a job into another field. During his career, he has released many successful products such as Prolia and Vectibix.

Carsten Thiel’s roles often required him to be a leader to his team and provide an example for them to follow. His sense of ethics made this easier because he would have to choose the options better for patients and products that would fare well in the long run, if not initially. Doing the right thing by his patients gives Thiel a sense of pride to know that the work he has done is not going unappreciated. As a result, sales and revenue for the company increased, as well as customers’ trust and faith in it. See This Page for additional information.

During Thiel’s time working with Amgen, Carsten Thiel was responsible for the launch of a product which would treat bone loss and fractures in women. The system being used at the time did not take into consideration all he possible patients who could need it, but instead a select few who were registered into the system and showed an obvious need. Carsten Thiel altered the system to uncover not-so-obvious patients and they were now able to discuss details and obtain the treatment.

This product is now one of the leading in the field of osteoporosis, providing more patients than ever with the care they need and deserve. Thiel’s compassion leads him to strive for patient satisfaction with all age ranges.

An article from IdeaMensch entitled: “Carsten Thiel: Pharmaceutical & Biopharmaceutical Expert”, Thiel shared how he started his foray into the innovative realm of pharmaceuticals and further expressed his views about the “Golden Age of Biotechnology”.


Like him on

Carsten Thiel Explains Why We Should All Be Excited About Biotechnology


Biotechnology is having its moment in the sun as it were. We have seen numerous industries come into their own in recent years. The technology industry is among the most celebrated of these as the giants of the tech sector have managed to create a massive number of products that we use and gain something from in our lives. Now, it is the time for biotechnology.

The central issue that biotechnology seeks to take on as Carsten Thiel sees it is to help human beings to live as long and healthy as possible. That is the goal that all of us have when it is all said and done. We want to get the most out of our lives.

Dr. Carsten Thiel is an expert in the field of biotechnology, who shares the view that the commercialization of gene therapies has become feasible as a result of ever-increasing efficiency and lower overhead involved in implementing technological innovations.

Carsten Thiel points to the decreasing cost of technology as a major factor in biotechnology getting a jump start. In just the last two decades we have seen plenty of medical advances that we did not believe were possible before. Visit This Page for more information.

Another reason why we have seen increases in the biotechnology field is the fact that we now have a better understanding of the way that human biology works. We know things such as the fact that cellular biology plays a major role in the way that we live and grow. We continue to conduct experiments, but we have made a lot of headway towards getting a full grasp on what is going on within ourselves.

Considering all of this, Carsten Thiel believes that biotechnology is going to continue to zoom forward into the next decades.


See also: